Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual reality game boosts arm recovery in chronic stroke patients

NCT ID NCT07534124

Symptom relief Sponsor: Universidad Complutense de Madrid Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a non-immersive virtual reality system (MindMotion GO) could help people with chronic stroke improve arm function better than standard occupational therapy. Twenty-six adults who had a stroke more than 6 months ago participated in 8 weeks of training. The results will show if this fun, engaging approach can boost recovery and quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

26 people

The number who actually took part.

Started

Sep 2022

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Participants must meet all of the following criteria: * Age between 18 and 80 years. * Chronic phase of ischemic stroke affecting the dominant hemisphere in the Middle Cerebral Artery territory (more than 6 months and less than 4 years since stroke onset). * Ability to actively extend the wrist at least 20 degrees and extend the fingers at least 10 degrees. * Upper limb muscle strength of the paretic limb ≥2 in the shoulder, elbow, and wrist. * Adequate trunk control. * Adequate vision and hearing to interact with the rehabilitation platform. * Ability to collaborate and follow study procedures. * Meeting safety criteria for Electroencephalography recording. * Signed informed consent. Exclusion Criteria: Participants will be excluded if any of the following conditions are present: * Severe cognitive impairment (Montreal Cognitive Assessment score \<10). * Major depression or emotional disorders associated with severe attention or cooperation deficits that may interfere with hand function. * Severe psychiatric disease. * Severe spasticity in the affected limb (Modified Modified Ashworth Scale ≥3-4). * Aphasia preventing comprehension of verbal instructions. * Visuospatial neglect preventing interaction with the rehabilitation interface. * Participation in other upper limb rehabilitation therapies during the study period. * Severe functional dependency prior to stroke. * History of other strokes occurring after the index stroke. * Any medical condition that, in the opinion of the investigator, could interfere with study participation or data interpretation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic ischemic stroke of the middle cerebral artery territory are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Ischemic Stroke middle cerebral artery infarction Paresis stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic stroke patient Rehabilitation Stroke Upper limb paresis

Contacts and locations

Locations

  • Complutense University of Madrid

    Madrid, Madrid, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.